Form 4: Herbalife Director Michael J. Levitt Awarded New RSUs

Sentiment:

Statement of Changes in Beneficial Ownership


Herbalife Ltd. director Michael J. Levitt has been granted 11,879 restricted stock units as part of the company's 2023 Stock Incentive Plan.

Summary

  • Director Michael J. Levitt acquired 11,879 restricted stock units (RSUs) on May 8, 2026.
  • The RSUs were granted at a price of $0.00 as part of director compensation.
  • Following this transaction, Levitt's total beneficial ownership in Herbalife Ltd. increased to 49,393 shares.
  • The granted units are scheduled to vest 100% on April 15, 2027, contingent upon continued service on the Board of Directors.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive administrative event. While it is a routine grant, it increases the director's skin in the game and confirms continued board stability.

Positives

  • The grant increases the director's total stake in the company to 49,393 shares, further aligning his interests with those of the shareholders.
  • The 100% vesting requirement on April 15, 2027, encourages long-term commitment to the board.

Negatives

  • The acquisition was a grant rather than an open-market purchase, meaning no personal capital was committed by the director at this time.

Risks

  • Vesting of the 11,879 RSUs is subject to the risk of forfeiture if the reporting person does not continue service on the Board of Directors through April 15, 2027.

Future Outlook

The reporting person is expected to remain on the Board of Directors through at least April 15, 2027, to satisfy the vesting conditions of the newly granted equity units.

Management Comments

  • The RSUs will vest 100% on April 15, 2027, subject to continued service on the Issuer's Board of Directors through such date.

Industry Context

StockSavvy.ai notes that equity-based compensation for non-employee directors is a standard practice among mid-cap companies like Herbalife to ensure board members are incentivized to drive long-term share price appreciation, similar to peers in the health and wellness sector.

Comparison to Industry Standards

  • The use of a one-year cliff vesting period for director RSUs is consistent with corporate governance standards seen at peer companies such as USANA Health Sciences and Nu Skin Enterprises.
  • The grant size is within the typical range for director compensation in the consumer staples and personal products industry.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Equity GrantGrant of RSUs under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan.2026-05-08Aligns director compensation with shareholder interests through equity-based incentives.

Stakeholder Impact

  • Shareholders may view the increased equity ownership by a director as a positive sign of commitment to the company's future.

Next Steps

  • Vesting of 11,879 shares on April 15, 2027.

Key Dates

DateDescription
2026-05-08Date of the transaction where 11,879 RSUs were granted.
2026-05-12Date the Form 4 filing was signed and submitted to the SEC.
2027-04-15Scheduled date for 100% vesting of the granted restricted stock units.

Recommendation

hold

This filing represents a routine compensation event for a director and does not provide new material information regarding the company's operational performance or financial health that would warrant a change in investment rating.

Keywords

Herbalife Ltd., HLF, Insider Trading, Form 4, Restricted Stock Units, Michael J. Levitt, Director Compensation, Equity Grant

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.